Charlottesville, VA, United States of America

Panagiotis Mastorakos

This inventor holds 6 USPTO granted patents and 2 published patent applications, plus 2 CIPO patents. Top assignee: Johns Hopkins University. Active years: 2018-2021.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Panagiotis Mastorakos. Retrieved from https://idiyas.com/inventor/panagiotis-mastorakos

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 6 

% Patents Active = 100.0


Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Location History:

  • Charlottesville, VA (US) (2018 - 2021)
  • Charlottsville, VA (US) (2021)

Company Filing History:


Years Active: 2018-2021

Loading Chart...
Loading Chart...
6 patents (USPTO):Explore Patents

Title: Innovations by Panagiotis Mastorakos

Introduction

Panagiotis Mastorakos is a prominent inventor based in Charlottesville, VA, known for his significant contributions to the field of gene delivery systems. With a total of six patents to his name, he has made remarkable strides in developing innovative solutions for overcoming biological barriers in medical applications.

Latest Patents

Mastorakos's latest patents include "Highly stable biodegradable gene vector platforms for overcoming biological barriers." This invention addresses the challenges in non-viral gene delivery by providing a safe and effective delivery system. The gene vectors are designed to be biodegradable, non-toxic, and highly customizable for specific applications. They consist of a mixture of biodegradable copolymers and hydrophilic polymers, demonstrating broad vector distribution and high transgene delivery in vivo.

Another notable patent is "Selective dendrimer delivery to brain tumors." This composition involves poly(amidoamine) (PAMAM) hydroxyl-terminated dendrimers that are covalently linked to therapeutic agents for treating brain tumors. The dendrimers exhibit high uptake into the brain, allowing for selective delivery of various agents through the blood-brain barrier. This innovation provides a promising approach for simultaneous delivery of multiple therapeutic compounds.

Career Highlights

Panagiotis Mastorakos is affiliated with The Johns Hopkins University, where he continues to advance research in gene delivery systems. His work has garnered attention for its potential impact on therapeutic applications, particularly in the treatment of brain tumors and other medical conditions.

Collaborations

Mastorakos collaborates with esteemed colleagues, including Justin Scot Hanes and Jung Soo Suk, who contribute to the research and development of innovative medical solutions.

Conclusion

Panagiotis Mastorakos is a leading inventor whose work in biodegradable gene vectors and dendrimer delivery systems is paving the way for advancements in medical therapies. His contributions are vital in addressing significant challenges in the field of gene delivery, showcasing the importance of innovation in healthcare.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…